THERAtRAME
Ching Man Choi is the Chief Executive Officer at THERAtRAME. Prior to joining THERAtRAME, Ching Man Choi held the role of Business Development / Investor Relations Manager at BONE THERAPEUTICS S.A. and Financial & Business Analyst at Hospidex. Ching Man Choi also has experience as an Associate Scientist at VIB and as a panel coordinator at Vlerick Business School. Ching Man Choi holds a Master's degree in Financial Management from Vlerick Business School, a PhD Fellow in Human Genetics- Neuroscience from KU Leuven, and a Master's degree in Biochemistry from the University of Antwerp.
This person is not in any teams
THERAtRAME
THERAtRAME mission is to therapeutically exploit the common translation mechanisms necessary for the development of human pathologies in order to cure up to now untreatable diseases.